Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × patritumab deruxtecan × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 14 Active not recruiting 6 Completed 2 Withdrawn 1 Unknown 1 Terminated 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cisplatin 513 Radiotherapy 375 Cyclophosphamide 363 Carboplatin 354 Capecitabine 338 Paclitaxel 331 Oxaliplatin 329 Docetaxel 313 Gemcitabine 311 Fluorouracil 286 Drug Therapy 264 apatinib 246 Bevacizumab 242 camrelizumab 217 Etoposide 199 Irinotecan 181 Doxorubicin 180 Dexamethasone 159 Leucovorin 158 pembrolizumab 151 Cytarabine 141 sintilimab 140 Blood Specimen Collection 140 anlotinib 139 Neoadjuvant Therapy 139 Pemetrexed 137 toripalimab 126 Surgical Procedures, Operative 125 Radiosurgery 125 S 1 (combination) 124

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04610528 2023-06-23

TOT-HER3

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡